(Q33167870)

English

Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors

scientific article

Statements

Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors (English)
0 references
0 references
Elizabeth M Blackwood
Srikumar Sahasranaman
Jennifer L Schutzman

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit